Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Tony Sedgwick, Thomas Christely

Premium

Silence Therapeutics has appointed chief business officer Tony Sedgwick as its new CEO following the resignation of Thomas Christely.

Sedgwick joined Silence last September. Before that, he was CEO of Novacta, Daniolabs, and Cambridge Biotechnology.

Christely was previously CEO of Atugen, which was later acquired by Silence. He had served as Silence's COO until the departure of former CEO Philip Haworth last year. Silence said that Christely has also resigned his board seat.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.